CLINUVEL Pharmaceuticals Ltd

CLINUVEL is a global leader in photomedicine and has commercialised the first systemic photoprotective drug. The Group develops treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as PhotoCosmetics for specialised populations. Headquartered in Melbourne, Australia, CLINUVEL has operations in Europe, Singapore, and the USA.

View Site